Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, University of the Witwatersrand Medical School, 2193 Johannesburg, South Africa.
J Hypertens. 2013 Jun;31(6):1124-30. doi: 10.1097/HJH.0b013e328360802a.
We sought to determine whether within normal/high-normal blood pressure (BP) ranges (120-139/80-89 mmHg), aortic BP may further refine BP-related cardiovascular risk assessment, as determined from target organ changes.
In 1169 participants from a community sample of African ancestry, 319 (27%) of whom had a normal/high-normal BP, aortic BP was determined using radial applanation tonometry and SphygmoCor software, and target organ changes assessed from carotid-femoral pulse wave velocity (PWV) (n = 1025), estimated glomerular filtration rate (eGFR) (n = 944), and left ventricular mass indexed to height (LVMI) (n = 690).
Normal versus high-normal BP categories failed to differentiate between those participants with a BP above optimal values with versus without multivariate-adjusted target organ changes. However, in those with a normal/high-normal BP with aortic SBP values that were less than 95% confidence interval of healthy participants with optimal BP values (45% of those with a normal/high-normal BP), no unadjusted or multivariate adjusted target organ changes were noted. In contrast, those with a normal/high-normal BP with aortic SBP values that exceeded optimal thresholds, demonstrated unadjusted and multivariate adjusted increases in PWV and LVMI and decreases in eGFR (P < 0.05 to P < 0.005 after multivariate adjustments).
In contrast to normal versus high-normal BP categories which do not clearly distinguish normotensives with from those without organ damage, noninvasively determined aortic BP measurements may refine the ability to detect those with a normal/high-normal BP at risk of BP-related cardiovascular damage.
我们旨在确定在正常/正常高值血压(BP)范围内(120-139/80-89mmHg),主动脉 BP 是否可以进一步细化基于 BP 的心血管风险评估,这是根据靶器官变化来确定的。
在来自非洲裔人群的社区样本中,共纳入 1169 名参与者,其中 319 名(27%)参与者的血压为正常/正常高值,使用桡动脉平板张力测定法和 SphygmoCor 软件测定主动脉 BP,并通过颈动脉-股动脉脉搏波速度(PWV)(n=1025)、估算肾小球滤过率(eGFR)(n=944)和左心室质量指数(LVMI)(n=690)评估靶器官变化。
正常与正常高值 BP 类别无法区分那些血压高于最佳值且存在或不存在多变量调整后靶器官变化的参与者。然而,在那些正常/正常高值 BP 且主动脉 SBP 值低于健康参与者最佳 BP 值(45%的正常/正常高值 BP 参与者)的 95%置信区间的参与者中,没有观察到未调整或多变量调整后的靶器官变化。相比之下,那些正常/正常高值 BP 且主动脉 SBP 值超过最佳阈值的参与者,未调整和多变量调整后的 PWV 和 LVMI 增加,eGFR 降低(多变量调整后 P<0.05 至 P<0.005)。
与不能明确区分无器官损伤的正常血压与正常高值血压的正常与正常高值 BP 类别不同,非侵入性测定的主动脉 BP 测量值可能会提高检测正常/正常高值 BP 且有 BP 相关心血管损伤风险的能力。